发明公开
EP0156233A3 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
失效
用于生产CYPOPROTECTIVE PHARMACEUTICAL组合物的白蛋白拮抗剂的使用和生产CYPOPROTECTIVE PHARMACEUTICAL COMPOSITIONS的方法
- 专利标题： Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
- 专利标题（中）： 用于生产CYPOPROTECTIVE PHARMACEUTICAL组合物的白蛋白拮抗剂的使用和生产CYPOPROTECTIVE PHARMACEUTICAL COMPOSITIONS的方法
-
申请号： EP85102787申请日： 1985-03-12
-
公开(公告)号： EP0156233A3公开(公告)日： 1986-02-19
- 发明人: Goldenberg, Marvin M.
- 申请人： MERCK & CO. INC.
- 专利权人： MERCK & CO. INC.
- 当前专利权人： MERCK & CO. INC.
- 优先权： US590815 19840319; US685102 19841221
- 主分类号： A61K31/35
- IPC分类号： A61K31/35
摘要：
Leukotriene antagonists have been found to be useful for inducing cytoprotection via an unspecified mechanism. Specific therapeutic utilities include, erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol. The leukotriene antagonists are used to produce cytoprotective pharmaceutical compositions. In a process for producing cytoprotective pharmaceutical compositions the leukotriene antagonists are incorporated into a corresponding composition in a cytoprotective effective amount.
信息查询
